# A03-017 - Portfolio Traceability Initialization

## Program

Program A03 - Scientific Content Population: SSRIs.

## Phase

Phase 2 - Drug Portfolio Definition.

## Objective

Initialize the traceability layer for Program A03 so future objects can be traced to their documentary origins.

This mission does not consume evidence and does not create scientific knowledge.

## Created Artifacts

- `KnowledgeBase/SSRIs/Traceability/TRACEABILITY_REGISTRY.json`
- `KnowledgeBase/SSRIs/Traceability/TRACEABILITY_INDEX.json`
- `KnowledgeBase/SSRIs/Traceability/TRACEABILITY_STATUS.json`
- `KnowledgeBase/SSRIs/Traceability/TRACEABILITY_MANIFEST.json`
- `KnowledgeBase/SSRIs/Traceability/SOURCE_TO_OBJECT_MAP.json`
- `KnowledgeBase/SSRIs/Traceability/OBJECT_TO_SOURCE_MAP.json`

## Traceability Scope

The initialized traceability layer covers:

- registry objects created or linked by A03-016;
- source identifiers from the normalized SSRI source corpus;
- empty object-to-source and source-to-object mapping structures.

## Object Fields Prepared

Each traceability object has:

- object ID;
- object type;
- source ID list;
- editorial version;
- schema version;
- created at;
- updated at;
- validation status;
- publication status.

## Validation Status

- All registries have traceability structures.
- All sources can be referenced.
- No object is missing structure.
- No invalid source was introduced.

## Explicit Non-Actions

This mission did not:

- create knowledge;
- interpret sources;
- create Drug Profiles;
- create Mechanism content;
- create PK or PD content;
- create Safety content;
- create Interaction content.

## Next Mission

```text
MISSION A03-018 - EDITORIAL_STATUS_FRAMEWORK
```

## Declaration Final

A03-017 initializes traceability structures only. It does not authorize scientific content population, clinical interpretation, recommendation, prescription or runtime consumption.
